Skip to content

The Prevelence of IVS 1-6 (T-C) [HBB:c.92 +6 T-C] Gene Mutation in Suspected Cases of β Thalassemia in Assiut University Hospitals

The Prevelence of IVS 1-6 (T-C) [HBB:c.92 +6 T-C] Gene Mutation in Suspected Cases of β Thalassemia in Assiut University Hospitals

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05370677
Enrollment
141
Registered
2022-05-11
Start date
2022-05-31
Completion date
2024-12-31
Last updated
2022-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Beta-Thalassemia

Brief summary

1. \- To design an amplification-refractory mutation system (ARMS) for the DNA diagnosis of the IVS I-6 (T\>C) mutation. 2. \- To detect the prevelence of the mutation among Assiut University Hospital patients. 3. \- Phenotype/genotype correlation of the mutation.

Detailed description

• The β-thalassaemias result from 300 gene mutations ( https://globin.bx.psu.edu ). All of the mutations are regionally specific and the spectrum of mutations has now been determined for most at-risk populations(Old JM, 2007). * The strategy for identifying β-thalassaemia mutations is usually based on the knowledge of the common and rare mutations in the ethnic group of the individual being screened.(Old JM, 2007) . * In Mediterranean it represnts 8-15% * In Africa it represnts 3.5% * In Egyptians it represnts 13.6% ( https://globin.bx.psu.edu ). * The β globin gene mutation IVS I-6(T\>C) is the First most common β globin gene mutation among Egyptians * (36.3%) according to ( Somaia El-Gawhary et al 2007 ) * (27.66%) ( Ammar D. Elmezayen et al 2015 ) * and the second most common mutation * (40%) according to ( El-shanshory M et al 2014) * (21.25%) ( Elhalfawy et al 2017) The molecular characterization of the globin gene mutation is necessary for definite diagnosis, genetic counseling, and to offer prenatal diagnosis. The amplification-refractory mutation system (ARMS) is a simple method for detecting any mutation involving single base changes or small deletions. * the DNA is analysed after amplification by PCR for Detection of point mutation IVS I-6(T\>C) by Using primer pairs that only amplify individual alleles \[ARMS\] .

Interventions

GENETICARMS

amplification refractory mutation system

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* : β thalassemia (suspected & clinically diagnosed cases).

Exclusion criteria

* : Iron deficiency anaemia, anaemia of chronic disease, types of haemolytic anaemias other than thalassemia, other types of thalassemia and Hb variants

Design outcomes

Primary

MeasureTime frameDescription
using ARMS to detect the mutation2 years* To introduce the ARMS PCR as a cheap and simple DNA diagnostic tool for any point mutation. * Initiating the department database of haemoglobinopathesis by regisptering data.

Secondary

MeasureTime frameDescription
teaching purpose2 yearsteaching purpose

Contacts

Primary ContactFatma Elzahraa Mohamed Abd Elrady
fattmamohamedabdelrady@gmail.com01099696566

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026